Salihoglu, A. Et Al. 2015. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. ANNALS OF HEMATOLOGY , vol.94, no.3 , 415-420.

Salihoglu, A., Elverdi, T., Karadogan, I., Paydas, S., Ozdemir, E., Erdem, G., ... Karadurmus, N.(2015). Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. ANNALS OF HEMATOLOGY , vol.94, no.3, 415-420.

Salihoglu, A. Et Al. "Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey," ANNALS OF HEMATOLOGY , vol.94, no.3, 415-420, 2015

Salihoglu, A. Et Al. "Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey." ANNALS OF HEMATOLOGY , vol.94, no.3, pp.415-420, 2015

Salihoglu, A. Et Al. (2015) . "Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey." ANNALS OF HEMATOLOGY , vol.94, no.3, pp.415-420.

@article{article, author={A. Salihoglu Et Al. }, title={Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey}, journal={ANNALS OF HEMATOLOGY}, year=2015, pages={415-420} }